Skip to main content
OpenTrials
Completed

NCT Number: NCT00757471

Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Macular Hole Surgery with two different Dyes

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser surgery

Vienna, State of Vienna, 1030, Austria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Idiopathic stage 3 and 4 macular holes
  • Stage 2 macular holes, followed up for at least 6 months
  • Pseudophakic and phakic eyes
  • Age over 60 years

Exclusion criteria

  • Traumatic macular holes
  • Secondary macular holes
  • Severe ocular diseases

Treatment and study plan

Brillant Blue

Procedure

Membrane Peeling with Brillant Blue

Indocyanine Green

Procedure

Membrane Peeling with indocyanine Green

Primary outcomes

  1. Macular Hole Closure Rate

    Time frame: 12 Months

Secondary outcomes

  1. Visual Acuity Microperimetry Optical Coherence Tomography

    Time frame: 12 Months

Sponsors and collaborators

Lead sponsor

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Other

Registry information

Official study title

Membranepeeling With Brillant Blue Versus Membranepeeling With Indocyanine Green for Patients With Idiopathic Macular Holes.

Important dates

Study start
2008
Primary completion
2015
Study completion
2015
First posted
Sep 23, 2008
Registry last updated
Jan 26, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.